Evidence map›Paper›PMID 28545510›Full record

ArticleStem cell research & therapy2017

Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro.

Amanda B Sherman, Brian C Gilger, Alix K Berglund, Lauren V Schnabel

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Cell and Gene Therapy in Equine Ocular Disease.Veterinary ophthalmology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Use of Biologics for Hip Preservation.Current reviews in musculoskeletal medicine · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amanda B ShermanDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC, 27606, USA.
Brian C GilgerDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC, 27606, USA.
Alix K BerglundDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC, 27606, USA.
Lauren V SchnabelDepartment of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC, 27606, USA. lvschnab@ncsu.edu.

Funding

Equine iPS cells and their ability to enhance tendon regeneration in vivoK08AR060875 · NIAMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI SCHNABEL, LAUREN VIRGINIA · 2012 to 2016
$614k
NIAMS NIH HHS K08 AR060875
6 · The paper itself

Abstract

backgroundWe aimed to determine and compare the in vitro effects of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) and mesenchymal stem cell supernatant (MSC-Sp) on the wound healing capacity of equine corneal fibroblasts using a scratch assay.

methodsBone marrow aspirates and eyes were collected from normal, euthanized horses with subsequent isolation and culture of BM-MSCs and corneal stromal cells. Corneal stromal cells were culture-expanded in the culture well of transwell plates and then treated with an autologous BM-MSC suspension (dose: 2.5 × 10

resultsThere was a significant percentage decrease in the scratch area remaining in the BM-MSC and MSC-Sp groups compared to the control group. There was also a significant percentage decrease in the scratch area remaining in the BM-MSC group compared to the MSC-Sp group at 36 h post-scratch and all time points thereafter. The concentration of transforming growth factor (TGF)-β1 in the media was significantly higher in the BM-MSC group compared to the control group.

conclusionsThe significant decrease in scratch area in equine corneal fibroblast cultures treated with autologous BM-MSCs compared to MSC-Sp or control treatments suggests that BM-MSCs may substantially improve corneal wound healing in horses. MSC-Sp may also improve corneal wound healing given the significant decrease in scratch area compared to control treatments, and would be an immediately available and cost-effective treatment option.

Indexed as

Wound HealingAnimalsBiomarkersBone Marrow CellsCorneal InjuriesEnzyme-Linked Immunosorbent AssayEpidermal Growth FactorFemaleFlow CytometryHorsesMaleMesenchymal Stem CellsTransforming Growth Factor beta1BiomarkersEpidermal Growth FactorTransforming Growth Factor beta1Corneal stromal cells/ fibroblastsCorneal wound healingEquineMesenchymal stem cellsScratch assayTGF-β1

Identifiers

PMID28545510
PMCPMC5445363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.